Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
High Blood Pressure & Cardiovascular Prevention
Published in: High Blood Pressure & Cardiovascular Prevention 3/2008

01-07-2008 | Contributions from International Congress

11.7 Lifestyle Modifications: a Very Good Weapon Against Hypertension

Authors: A. Di Patria, A. Lerro, M. Pietrosante, V. Del Villano

Published in: High Blood Pressure & Cardiovascular Prevention | Issue 3/2008

Login to get access

Excerpt

Introduction. Although all the international guidelines suggest modifications in lifestyle in association with pharmacological therapy to obtain a better control on blood pressure (BP) and limit organ damage, and though advantage is obtained even in primary prevention, the focus on this field and the application in clinical practice are still poor and appropriate educational programmes are not completely available. …
Metadata
Title
11.7 Lifestyle Modifications: a Very Good Weapon Against Hypertension
Authors
A. Di Patria
A. Lerro
M. Pietrosante
V. Del Villano
Publication date
01-07-2008
Publisher
Springer International Publishing
Published in
High Blood Pressure & Cardiovascular Prevention / Issue 3/2008
Print ISSN: 1120-9879
Electronic ISSN: 1179-1985
DOI
https://doi.org/10.1007/BF03263715

Other articles of this Issue 3/2008

High Blood Pressure & Cardiovascular Prevention 3/2008 Go to the issue

Contributions from International Congress

12.3 Platelet Cyclic GMP Levels and the Aggregating Response to Adrenaline in Essential Hypertensive patients

Contributions from International Congress

9.10 Prognostic Relevance of Masked Hypertension in Subjects with Normal and High-Normal Clinic Blood Pressure

Contributions from International Congress

11.11 Effect of Valsartan-Amlodipine Combination on Cognitive Function In Elderly Hypertensive Patients

Contributions from International Congress

5.24 Obesity Increases the Effect of Sodium Intake on Left Ventricular Mass in Hypertensive Patients

Contributions from International Congress

12.18 Correlation between Ambulatory Arterial Stiffness Index (AASI) and Pulse Wave Velocity in a General Population: the Vobarno Study

Contributions from International Congress

9.16 Hypertension Leads to Type 2 Diabetes Mellitus

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits